Table Of Contents:
- Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
- Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
- Chapter 3. Biosurgery Market: By Product Type Market Trends, Size, and Future Outlook
- Hemostats Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Hemostats Definitions, Technology Landscape
- Hemostats Market Drivers
- Product Launches
- Technology Launches
- Hemostats Market Restraints
- Chapter 4. Biosurgery Market: By End-User Market Trends, Size, and Future Outlook
- Hospitals Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Hospitals Definitions, Technology Landscape
- Hospitals Market Drivers
- Product Launches
- Technology Launches
- Hospitals Market Restraints
- Chapter 5. Biosurgery Market: By Application Market Trends, Size, and Future Outlook
- Cardiovascular Surgery Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Cardiovascular Surgery Definitions, Technology Landscape
- Cardiovascular Surgery Market Drivers
- Product Launches
- Technology Launches
- Cardiovascular Surgery Market Restraints
- Chapter 6. Biosurgery Market: By Material Market Trends, Size, and Future Outlook
- Collagen-based Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Collagen-based Definitions, Technology Landscape
- Collagen-based Market Drivers
- Product Launches
- Technology Launches
- Collagen-based Market Restraints
- Chapter 7. Biosurgery Market: By Technology Market Trends, Size, and Future Outlook
- Tissue Engineering Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Tissue Engineering Definitions, Technology Landscape
- Tissue Engineering Market Drivers
- Product Launches
- Technology Launches
- Tissue Engineering Market Restraints
- Chapter 8. Biosurgery Market: Regional Market Trends, Size, and Future Outlook
- North America Trends, Market Size (US$), CAGR (%), and Future Outlook
- North America Market Size (US$), CAGR (%), and Forecast (2021-2031)
- North America Definitions, Technology Landscape
- North America Market Drivers
- Product Launches
- Technology Launches
- North America Market Restraints
- Europe Trends, Market Size (US$), CAGR (%), and Future Outlook
- Europe Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Europe Definitions, Technology Landscape
- Europe Market Drivers
- Product Launches
- Technology Launches
- Europe Market Restraints
- Asia Pacific Trends, Market Size (US$), CAGR (%), and Future Outlook
- Asia Pacific Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Asia Pacific Definitions, Technology Landscape
- Asia Pacific Market Drivers
- Product Launches
- Technology Launches
- Asia Pacific Market Restraints
- Latin America Trends, Market Size (US$), CAGR (%), and Future Outlook
- Latin America Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Latin America Definitions, Technology Landscape
- Latin America Market Drivers
- Product Launches
- Technology Launches
- Latin America Market Restraints
- Middle East, and Africa Trends, Market Size (US$), CAGR (%), and Future Outlook
- Middle East, and Africa Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Middle East, and Africa Definitions, Technology Landscape
- Middle East, and Africa Market Drivers
- Product Launches
- Technology Launches
- Middle East, and Africa Market Restraints
- Chapter 9. Biosurgery Market: Competitive Landscape
- Baxter International Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Johnson & Johnson
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Medtronic plc
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Becton, Dickinson and Company
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Integra LifeSciences Holdings Corporation
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Anika Therapeutics, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Wright Medical Group N.V.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Stryker Corporation
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Sanofi S.A.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Pfizer Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Ethicon, Inc. (a subsidiary of Johnson & Johnson)
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Arthrex, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Smith & Nephew plc
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Tissuegene, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Solvay S.A.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Coloplast A/S
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Zimmer Biomet Holdings, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Olympus Corporation
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Macopharma
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Grifols, S.A.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Baxter International Inc.
Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
Appendix
- About Us
Frequently Asked Questions
The current market size of the Biosurgery industry is US$ 11,542 million in 2023.
Key factors driving the growth of the Biosurgery market include the increasing prevalence of chronic diseases, the growing geriatric population, advancements in medical technology, the rising demand for minimally invasive surgical procedures, and the integration of AI and ML in biosurgical products.
The key factors hampering the growth of the Biosurgery Market include the high cost of biosurgical products, the stringent regulatory approval process, limited reimbursement coverage for some biosurgical procedures, and concerns about the availability and reliability of biological materials.
The leading component segment in the Biosurgery Market is the Hemostats segment, which plays a crucial role in controlling bleeding during surgical procedures.
The major players operating in the Biosurgery Market include Baxter International Inc., Johnson & Johnson, Medtronic plc, Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation, and Anika Therapeutics, Inc., among others.
The Biosurgery Market is expected to grow at a CAGR of 6.1% from 2024 to 2031, with a projected market size of US$ 18,535.5 million by 2031.
The key drivers of the Biosurgery Market include the increasing prevalence of chronic diseases, the growing geriatric population, advancements in medical technology, the rising demand for minimally invasive surgical procedures, and the integration of AI and ML in biosurgical products.